ClinicalTrials.govpublic full text
Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast Ca
breast adenocarcinoma, estrogen receptor- negative breast cancer, estrogen receptor-positive breast cancer, her2/neu negative, invasive breast carcinoma, progesterone receptor negative
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 429760
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.